Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 205

1.

Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study.

Schmid P, Nagai Y, Agarwal R, Hancock B, Savage PM, Sebire NJ, Lindsay I, Wells M, Fisher RA, Short D, Newlands ES, Wischnewsky MB, Seckl MJ.

Lancet. 2009 Jul 4;374(9683):48-55. doi: 10.1016/S0140-6736(09)60618-8. Epub 2009 Jun 22.

PMID:
19552948
2.

Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE).

Wang J, Short D, Sebire NJ, Lindsay I, Newlands ES, Schmid P, Savage PM, Seckl MJ.

Ann Oncol. 2008 Sep;19(9):1578-83. doi: 10.1093/annonc/mdn181. Epub 2008 May 2.

PMID:
18453518
3.

Management and outcome of healthy women with a persistently elevated beta-hCG.

Palmieri C, Dhillon T, Fisher RA, Young AM, Short D, Mitchell H, Aghajanian C, Savage PM, Newlands ES, Hancock BW, Seckl MJ.

Gynecol Oncol. 2007 Jul;106(1):35-43. Epub 2007 May 4.

PMID:
17482245
4.

Value of whole body 18FDG-PET to identify the active site of gestational trophoblastic neoplasia.

Dhillon T, Palmieri C, Sebire NJ, Lindsay I, Newlands ES, Schmid P, Savage PM, Frank J, Seckl MJ.

J Reprod Med. 2006 Nov;51(11):879-87.

PMID:
17165434
5.

Importance of accurate human chorionic gonadotropin measurement in the treatment of gestational trophoblast disease and testicular cancer.

Mitchell H, Bagshawe KD, Newlands ES, Savage P, Seckl MJ.

J Reprod Med. 2006 Nov;51(11):868-70. No abstract available.

PMID:
17165431
6.

Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment.

Murugaesu N, Schmid P, Dancey G, Agarwal R, Holden L, McNeish I, Savage PM, Newlands ES, Rustin GJ, Seckl MJ.

J Clin Oncol. 2006 Oct 20;24(30):4862-6.

PMID:
17050871
7.

Early change in glucose metabolic rate measured using FDG-PET in patients with high-grade glioma predicts response to temozolomide but not temozolomide plus radiotherapy.

Charnley N, West CM, Barnett CM, Brock C, Bydder GM, Glaser M, Newlands ES, Swindell R, Matthews J, Price P.

Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2):331-8. Epub 2006 Jul 12.

PMID:
16839701
8.

Evaluation of deletions in 7q11.2 and 8p12-p21 as prognostic indicators of tumour development following molar pregnancy.

Burke B, Sebire NJ, Moss J, Hodges MD, Seckl MJ, Newlands ES, Fisher RA.

Gynecol Oncol. 2006 Nov;103(2):642-8. Epub 2006 Jun 27.

PMID:
16806440
9.

A case report of a recurrent intracranial ependymoma treated with temozolomide in remission 10 years after completing chemotherapy.

Rehman S, Brock C, Newlands ES.

Am J Clin Oncol. 2006 Feb;29(1):106-7. No abstract available.

PMID:
16462515
10.

Emerging targeted treatments for malignant glioma.

Mulholland PJ, Thirlwell C, Brock CS, Newlands ES.

Expert Opin Emerg Drugs. 2005 Nov;10(4):845-54. Review.

PMID:
16262566
11.

High-dose chemotherapy and peripheral blood stem cell support in refractory gestational trophoblastic neoplasia.

El-Helw LM, Seckl MJ, Haynes R, Evans LS, Lorigan PC, Long J, Kanfer EJ, Newlands ES, Hancock BW.

Br J Cancer. 2005 Sep 19;93(6):620-1.

12.

Posterior reversible encephalopathy syndrome: a possible late interaction between cytotoxic agents and general anaesthesia.

Rangi PS, Partridge WJ, Newlands ES, Waldman AD.

Neuroradiology. 2005 Aug;47(8):586-90. Epub 2005 Jul 5.

PMID:
15997391
13.

Maintenance of fertility following treatment with temozolomide for a high grade astrocytoma.

Palmieri C, Brock C, Newlands ES.

J Neurooncol. 2005 Jun;73(2):185. No abstract available.

PMID:
15981111
14.

Placental-site trophoblastic tumour: an unusual presentation with bilateral ovarian involvement.

Palmieri C, Fisher RA, Sebire NJ, Smith JR, Newlands ES.

Lancet Oncol. 2005 Jan;6(1):59-61. No abstract available.

PMID:
15629277
15.

Gestational trophoblastic neoplasia: the management of relapsing patients and other recent advances.

Sarwar N, Newlands ES, Seckl MJ.

Curr Oncol Rep. 2004 Nov;6(6):476-82. Review.

PMID:
15485618
16.

Familial recurrent hydatidiform mole: a review.

Fisher RA, Hodges MD, Newlands ES.

J Reprod Med. 2004 Aug;49(8):595-601. Review.

PMID:
15457849
17.

Routine terminations of pregnancy--should we screen for gestational trophoblastic neoplasia?

Seckl MJ, Gillmore R, Foskett M, Sebire NJ, Rees H, Newlands ES.

Lancet. 2004 Aug 21-27;364(9435):705-7.

PMID:
15325836
18.

Increased gestational age at evacuation of a complete hydatidiform mole: does it correlate with increased risk of requiring chemotherapy?

Seckl MJ, Dhillon T, Dancey G, Foskett M, Paradinas FJ, Rees HC, Sebire N, Vigushin DM, Newlands ES.

J Reprod Med. 2004 Jul;49(7):527-30.

PMID:
15305823
19.

p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy.

Sebire NJ, Rees HC, Peston D, Seckl MJ, Newlands ES, Fisher RA.

Histopathology. 2004 Aug;45(2):135-41.

PMID:
15279631
20.

The correlation between fetal hemoglobin and outcome in non-Hodgkin's lymphoma.

Wolk M, Newlands ES.

Int J Biol Markers. 2004 Apr-Jun;19(2):168-9. No abstract available.

PMID:
15255552
21.

Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours.

McNeish IA, Kanfer EJ, Haynes R, Giles C, Harland SJ, Driver D, Rustin GJ, Newlands ES, Seckl MJ.

Br J Cancer. 2004 Mar 22;90(6):1169-75.

22.

The management of recurrent and drug-resistant gestational trophoblastic neoplasia (GTN).

Newlands ES.

Best Pract Res Clin Obstet Gynaecol. 2003 Dec;17(6):905-23. Review.

PMID:
14614889
23.

Infertility rates following POMB/ACE chemotherapy for male and female germ cell tumours - a retrospective long-term follow-up study.

Gaffan J, Holden L, Newlands ES, Short D, Fuller S, Begent RH, Rustin GJ, Seckl MJ.

Br J Cancer. 2003 Nov 17;89(10):1849-54.

24.

Genetic refinement and physical mapping of a biparental complete hydatidiform mole locus on chromosome 19q13.4.

Hodges MD, Rees HC, Seckl MJ, Newlands ES, Fisher RA.

J Med Genet. 2003 Aug;40(8):e95. No abstract available.

25.

Phase I study of temozolamide (TMZ) combined with procarbazine (PCB) in patients with gliomas.

Newlands ES, Foster T, Zaknoen S.

Br J Cancer. 2003 Jul 21;89(2):248-51.

26.

Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy.

Sebire NJ, Fisher RA, Foskett M, Rees H, Seckl MJ, Newlands ES.

BJOG. 2003 Jan;110(1):22-6.

27.

Subvoxel image registration of multislice (2D) magnetic resonance images in patients with high-grade gliomas of the brain.

Oatridge A, Hajnal JV, Saeed N, Newlands ES, Curati WL, White SJ, Puri BK, Bydder GM.

Clin Radiol. 2002 Dec;57(12):1098-108.

PMID:
12475535
28.

The maternally transcribed gene p57(KIP2) (CDNK1C) is abnormally expressed in both androgenetic and biparental complete hydatidiform moles.

Fisher RA, Hodges MD, Rees HC, Sebire NJ, Seckl MJ, Newlands ES, Genest DR, Castrillon DH.

Hum Mol Genet. 2002 Dec 15;11(26):3267-72.

PMID:
12471053
29.

Quantification of human telomerase reverse transcriptase mRNA in testicular germ cell tumors by quantitative fluorescence real-time RT-PCR.

Schrader M, Burger AM, Müller M, Krause H, Straub B, Smith GL, Newlands ES, Miller K.

Oncol Rep. 2002 Sep-Oct;9(5):1097-105.

PMID:
12168080
30.

Management of brain metastases in patients with high-risk gestational trophoblastic tumors.

Newlands ES, Holden L, Seckl MJ, McNeish I, Strickland S, Rustin GJ.

J Reprod Med. 2002 Jun;47(6):465-71.

PMID:
12092015
31.

Twenty-five years' clinical experience with placental site trophoblastic tumors.

Papadopoulos AJ, Foskett M, Seckl MJ, McNeish I, Paradinas FJ, Rees H, Newlands ES.

J Reprod Med. 2002 Jun;47(6):460-4.

PMID:
12092014
32.

Outcome of twin pregnancies with complete hydatidiform mole and healthy co-twin.

Sebire NJ, Foskett M, Paradinas FJ, Fisher RA, Francis RJ, Short D, Newlands ES, Seckl MJ.

Lancet. 2002 Jun 22;359(9324):2165-6.

PMID:
12090984
33.

Doppler ultrasonography of the uterine artery and the response to chemotherapy in patients with gestational trophoblastic tumors.

Agarwal R, Strickland S, McNeish IA, Patel DC, Foskett M, Boultbee JE, Newlands ES, Seckl MJ.

Clin Cancer Res. 2002 May;8(5):1142-7.

34.

Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.

McNeish IA, Strickland S, Holden L, Rustin GJ, Foskett M, Seckl MJ, Newlands ES.

J Clin Oncol. 2002 Apr 1;20(7):1838-44.

PMID:
11919242
35.

Embolization of bleeding residual uterine vascular malformations in patients with treated gestational trophoblastic tumors.

Lim AK, Agarwal R, Seckl MJ, Newlands ES, Barrett NK, Mitchell AW.

Radiology. 2002 Mar;222(3):640-4.

PMID:
11867779
36.

The effect of early pregnancy following chemotherapy on disease relapse and foetal outcome in women treated for gestational trophoblastic tumours.

Blagden SP, Foskett MA, Fisher RA, Short D, Fuller S, Newlands ES, Seckl MJ.

Br J Cancer. 2002 Jan 7;86(1):26-30.

37.

Bilateral chylothorax due to retrosternal goiter in a patient with non-Hodgkin's lymphoma.

Simmgen M, Newlands ES, Southcott BM, Vigushin DM.

Med Oncol. 2001;18(2):153-7.

PMID:
11778762
38.

Pseudo-partial moles: placental stem vessel hydrops and the association with Beckwith-Wiedemann syndrome and complete moles.

Paradinas FJ, Sebire NJ, Fisher RA, Rees HC, Foskett M, Seckl MJ, Newlands ES.

Histopathology. 2001 Nov;39(5):447-54.

PMID:
11737301
39.

Management of ovarian germ cell tumours.

Newlands ES.

Forum (Genova). 2000 Oct-Dec;10(4):368-80. Review.

PMID:
11535986
40.

A retrospective comparison of current and proposed staging and scoring systems for persistent gestational trophoblastic disease.

Hancock BW, Welch EM, Gillespie AM, Newlands ES.

Int J Gynecol Cancer. 2000 Jul;10(4):318-322.

PMID:
11240693
41.

Regarding ligation of the hypogastric artery and blood loss.

Smith JR, Bridges JE, Boyle DC, Seckl M, Newlands ES.

Int J Gynecol Cancer. 2000 Mar;10(2):173. No abstract available.

PMID:
11240671
42.

Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases.

Cole LA, Shahabi S, Butler SA, Mitchell H, Newlands ES, Behrman HR, Verrill HL.

Clin Chem. 2001 Feb;47(2):308-15.

43.

Surveillance for stage I testicular germ cell tumours: results and cost benefit analysis of management options.

Francis R, Bower M, Brunström G, Holden L, Newlands ES, Rustin GJ, Seckl MJ.

Eur J Cancer. 2000 Oct;36(15):1925-32.

PMID:
11000572
44.

Choriocarcinoma and partial hydatidiform moles.

Seckl MJ, Fisher RA, Salerno G, Rees H, Paradinas FJ, Foskett M, Newlands ES.

Lancet. 2000 Jul 1;356(9223):36-9.

PMID:
10892763
45.

Amniotic tissue in complete hydatidiform moles can be androgenetic.

Weaver DT, Fisher RA, Newlands ES, Paradinas FJ.

J Pathol. 2000 May;191(1):67-70.

PMID:
10767721
46.

Repetitive complete hydatidiform mole can be biparental in origin and either male or female.

Fisher RA, Khatoon R, Paradinas FJ, Roberts AP, Newlands ES.

Hum Reprod. 2000 Mar;15(3):594-8.

PMID:
10686202
49.

A molecular cytogenetic approach to studying platinum resistance.

Hiorns LR, Seckl MJ, Paradinas F, Sharp SY, Skelton LA, Brunstrom G, Newlands ES, Kelland LR, Leyland-Jones B.

J Inorg Biochem. 1999 Oct;77(1-2):95-104.

PMID:
10626360
50.

Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas.

Balesaria S, Brock C, Bower M, Clark J, Nicholson SK, Lewis P, de Sanctis S, Evans H, Peterson D, Mendoza N, Glaser MG, Newlands ES, Fisher RA.

Br J Cancer. 1999 Dec;81(8):1371-7.

Supplemental Content

Loading ...
Support Center